Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.
The item "Return-On-Total-Capital" stands at 8.52 percent as of 06/30/2025.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Return On Total Capital" stands at 8.52 Percent. This represents an increase of 0.08 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -1.27 percentage points compared to the value the year prior.
The 1 year change in percentage points is -1.27.
The 3 year change in percentage points is -10.66.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Return On Total Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Return On Total Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Return On Total Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Return On Total Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Return On Total Capital | 280,205,508,085.11 |